By End User / Care Setting

Hospitals & Inpatient (Acute Care) Market Analysis

Cross-industry research covering Hospitals & Inpatient (Acute Care) across 1 market reportspanning Pharmaceuticals.

1 Reports

1 Industries

Reports Covering Hospitals & Inpatient (Acute Care)

Hospital Acquired Infection Control Market to Reach USD 41.6B by 2033 at 6.4% CAGR

Pharmaceuticals·Market: USD 25.3 Billion (2025)·CAGR: 6.4%

The dominant care setting by a wide margin, acute-care hospitals procure IV antibiotics, antifungals, and disinfectants through GPO-negotiated contracts, where Cardinal Health (edgar:CAH-10K-2025) and similar distributors hold structural leverage. CMS HAC Reduction Program penalties make infection-control investment a financial imperative, not discretionary spend.

52%

Market Share

6.1%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments